MedPageToday
MedPage Today) — Drugmaker Sarepta Therapeutics said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators.
The FDA said it recommended lifting the hold for young patients with Duchenne…
Read More
Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death
MedPage Today) — Drugmaker Sarepta Therapeutics said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The FDA said it recommended lifting the hold for young patients with Duchenne…